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Introduction
The meniscus plays a vital role in knee joint mechanics, 
including force transmission, shock absorption, joint stabil-
ity, lubrication, and proprioception. Meniscus injuries 
remain a difficult challenge in orthopedics, particularly 
with lesions located in the inner-most avascular regions, 
because research has repeatedly shown that avascular tears 
of the meniscus do not heal adequately.1-7 Capillaries from 
the lateral and medial geniculate arteries only penetrate 
peripherally to a depth of 10% to 30% of the width of the 
medial meniscus and only 10% to 25% of the width of the 
lateral meniscus.8 Meniscal fibrochondrocytes also lack 
sufficient scaffolding in which to mount effective wound 
repair.9
Orthopedic surgeons commonly perform meniscecto-
mies when treating torn menisci by simply debriding torn 
meniscal tissue. However, studies have shown that meniscal 
repairs have better outcomes over meniscectomies and that 
resection of the meniscus can predispose the knee joint to 
degenerative changes.10,11 Successful surgical restoration of 
damaged menisci has always been a challenge to the 
orthopedic surgeon. Numerous strategies to repair and 
replace meniscus have achieved only limited success.11 A 
number of different surgical procedures are available to 
achieve stabilization of the defect, such as staples and 
arrows. A number of techniques have also been described to 
repair menisci, such as inside-out, outside-in, or all-inside 
suturing techniques.8 These procedures frequently do not 
produce an integrative, functional repair.12 In the past, com-
plete excision of the injured meniscus was used, but found 
to result in early onset of osteoarthritis.2,13 At present, the 
most common surgical approach is arthroscopic examina-
tion and adequate partial menisectomy of the injured por-
tion of the meniscus.13-17 However, the patient is potentially 
subjected to a chronic course of degenerative changes sec-
ondary to altered biomechanics.
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Abstract
Objective. Studies have shown that meniscal repairs have better outcomes over both partial and total meniscectomies. 
Tissue engineering strategies to repair meniscus tears have been explored using cell sources that involve a donor as well 
as a period of in vitro cell expansion before use. This study explored cell sources that could be easily harvested and rapidly 
isolated by enzymatic digestion and cannulated delivery. Methods. Bovine menisci were used to create a bucket handle 
tear. Cell lines were established from meniscus, synovium, and adipose tissue and fluorescently labeled. At passages P2, P4, 
and P8, cells were added to the defect from the following experimental groups: cells alone, collagen gel, collagen scaffold, 
or hyaluronic acid. Menisci constructs were xenografted subcutaneously onto the dorsum of athymic rats and incubated 
for 3, 6, and 9 weeks, at which time they were retrieved and processed for histology. Results. Meniscal cells were able to 
repair defects faster and significantly better than adipose or synovium derived cells. Adipose cells were the least effective in 
comparison. Repair was significantly better at 9 weeks compared with 6 and 3 weeks. Macroscopic examination of menisci 
that received cell implants showed the thickest tissue in menisci that had collagen implants, and the thinnest fill occurred 
in menisci treated with cells alone. Histology confirmed no cells or integrative repair in the control specimens. Conclusions. 
Delivery of cells alone outperformed the additional use of biomaterials. Our results suggest a strategy that would use both 
meniscus and synovial cells for arthroscopic meniscal repair.
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The utility of applying principles of tissue engineering to 
meniscus tears has been explored in several reports in the lit-
erature.11,18,19 These have generally been successful in bridging 
clinically relevant meniscus lesions with mechanically stable 
repairs. The cell source in most of these studies have involved 
both meniscal cells themselves as well as other potential allo-
geneic cell sources such as articular cartilage, auricular carti-
lage, and marrow stromal cells. All these cell sources involve a 
donor as well as a period of in vitro cell expansion before they 
can be introduced into meniscus defects.
Tissue engineering combines the technologies of cell 
culture and biodegradable scaffolds to deliver a cellular 
repair, and may hold one future answer to the problem of 
meniscus healing. The concept of using cell-based repair 
for torn menisci could improve the healing of lesions in the 
avascular zone and broadly expand the indication for repair 
rather than removal, obviating the need for meniscectomy.18 
The use of cells and cell constructs for promoting meniscus 
repair has been investigated with some success.11,19
The purpose of the present study was to explore cell 
sources that could, in principle, be easily harvested in a rea-
sonably rapid time frame by enzymatic digestion and cannu-
lated delivery. In this study, we chose synovial derived cells 
and adipose derived cells because of their ease of utility for 
the proposed application, and compared them to meniscus 
cells as a benchmark standard. We also looked at several 
methods to deliver the cells that could be adapted for use by 
arthroscopic methods including fibrillar scaffolds and hydro-
gels. Furthermore, we also studied the effect of cell doubling 
in vitro in order to determine if these cells could not only be 
applied to a perioperative time frame but could possibly be 
stable in vitro for a period of time, and thus have utility as an 
expanded population capable of multiple patient use.
Methods
Cell Isolation and Culture
Meniscus Cell Isolation and Culture. Meniscal fibrochondrocyte 
cell lines were established from adult bovine knee joints fol-
lowing the dissection and harvest of menisci. Meniscal tissue 
was minced into pieces approximately 1 to 2 mm3 under sterile 
conditions. The tissue was then washed twice with culture 
medium and then weighed. The tissue was then digested over-
night in a 0.2% collagenase solution under constant stirring at 
37°C. The cell suspension was subsequently filtered through a 
100-µm cell strainer to separate any undigested material, and 
then centrifuged for 10 minutes at 1,300 rpm. The pellet was 
resuspended in culture medium and counted. Cells were then 
plated in culture with complete medium (DMEM with 10% 
fetal bovine serum) at a density of 10,000 cells/cm2. Culture 
was continued at 37°C, 5% CO
2
, and 95% humidity until use.
Adipose and Synovial Derived Cell Isolation and Culture. Syno-
vial and adipose tissue were harvested from bovine knee 
joints by careful dissection and biopsy of the identified tis-
sue types. The tissue was weighed and preheated medium at 
37°C. DMEM (Walkersville MD) was added to the Petri 
dishes to avoid dehydration. The tissues were then washed 
several times and then minced with a sterile pair of tweezers 
and a sterile scalpel. The minced tissue was transferred to a 
sterile tube containing 10 mL DMEM with antibiotic 
(DMEM-AB). A 0.4% collagenase solution in DMEM-AB 
was prepared with 15 mL digestion medium per gram of 
biopsy material. After passing through a sterile filter, the 
collagenase solution was added to the minced tissue. Four-
millimeter sterile borosilicate beads were then added to the 
minced tissue (3 mL glass beads/tube). The tube was then 
placed in a vertical rotor and allowed to digest for 4 hours at 
37°C. The vertical rotor was employed to increase the shear 
stress within the tube. After digestion, the cell suspension 
was sieved through a 100-µm cell strainer and subsequently 
through a 70-µm cell strainer. Undigested pieces of tissue 
were discarded. The cell suspension was centrifuged at 
1,500 rpm for 10 minutes, counted, and plated in culture at 
a density of 10,000 cells/cm2. Culture was continued at 
37°C, 5% CO
2
, and 95% humidity until use.
Scaffolds Utilized
In addition to using cells alone, the following biomaterial 
scaffolds were employed as cell delivery vehicles:
Collagen gel: High-density collagen gel (Nutragen 6 
mg/mL; Advanced Biomatrix, San Diego, CA) was 
prepared according to the manufacturer’s specifica-
tions. Briefly, acid collagen solution was neutralized 
with 0.1 M NaOH and kept on ice until cell mixing 
(100,000 cells/10 µL). The cell-collagen gel mixture 
was then pipetted directly into the meniscus defect 
and allowed to polymerize for 10 minutes at 37°C.
Collagen scaffold: Type I fibrous collagen scaffold 
(Kensey-Nash, Exton, PA), 2-mm thick type I colla-
gen scaffolds were seeded with cells (106 cells/0.5 
cm2) just prior to surgical implantation. The collagen 
scaffold was then cut to fit the meniscal defect and 
inserted into the defect site.
Hyaluronic acid (HA): High-molecular weight HA of 
approximately 4 kDa molecular weight (A gift from 
Dr. Phillip Band, New York University) was used as a 
carrier to deliver cells. Cells were mixed with HA at 
100,000 cells/10 µL prior to implantation and injected 
into the meniscus defect site.
Cell Labeling
Cells were pulsed for long-term staining during the log 
phase of in vitro growth with CellTracker Green (Lonza, 
Walkersville, MD) for subsequent localization studies. 
Following cell attachment before each scheduled passage, 
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cells were rinsed of medium and replaced with prewarmed 
media containing the cell tracker probe (10 µM) for 45 min-
utes. The probe solution was replaced with prewarmed 
media for another 30 minutes before further manipulation. 
After fixation of tissue samples and processing for histol-
ogy (described below), slides were viewed on an Olympus 
OM-2 microscope with epiflourescent capability.
Preparation of Meniscus Xenografts
Menisci were harvested from bovine knee joints and cut 
into 1.5-cm radical segments. A bucket handle tear was cre-
ated using a scalpel and either left empty, filled with a cell 
graft as described above, or filled with a cell biomaterial 
construct and closed with a nylon 6-0 suture. Menisci were 
wrapped in a nytex screen to exclude host cells, and then 4 
menisci constructs were xenografted subcutaneously onto 
the dorsum of each athymic rat (350-400 g) and incubated 
in vivo for 3, 6, and 9 weeks, at which time they were 
retrieved and processed for histology.
Experimental Design
Cells prepared from the 3 different tissue compartments—
meniscus, synovium, and adipose tissue—and cultured as 
described above. At specific cell passage numbers of P2, 
P4, and P8, the cells were trypsinized, washed, pelleted, and 
allocated to one of the following experimental groups: (a) 
cells alone, pipetted directly into the previously created 
meniscus defects (typical volume was 20-40 µL containing 
2-3 million cells); (b) collagen gel; (c) collagen scaffold; or 
(d) hyaluronic acid. Meniscus defects that were left 
untreated served as the control group. The various meniscus 
xenograft groups were implanted as described above for 3, 
6, and 9 weeks.
Histological Preparation and Analysis
Rats were sacrificed at 3, 6, and 9 weeks postimplantation. 
Samples were harvested and examined macroscopically for 
evidence of healing and then fixed in 10% buffered forma-
lin. Samples were then dehydrated and embedded in paraf-
fin. Five-micrometer-thick sections were either stained with 
hematoxylin and eosin or Mallory’s trichrome stain. 
Unstained sections were examined with a fluorescent 
microscopy to localize cells within the defect. To evaluate 
the degree of repair in each of the groups, we used a scoring 
system similar to those used in scoring tendon repair. The 
scale ranged from 0 to 4 with the following characteristics:
0: No healing observed, empty void space with defect 
clearly present
1: Minimal healing present with some integrative repair 
observed on one or both sides of the defect
2: Moderate healing observed with 25% to 50% integra-
tion of the surrounding tissue present
3: Abundant healing present 50% to 75% integration 
present
4: Healing nearly complete with full (>75%) integration 
observed
Each specimen was independently evaluated by 2 blinded 
observers and a minimum of 20 fields and 10 sections were 
scored.
Results
Cell Culture
All the cell types used were easily cultured and displayed a 
typical fibroblastoid appearance in monolayer culture. The 
rate of the cell growth was similar for adipose and synovial 
cells, whereas meniscus cells were slower by 1 to 2 days 
before needing to be passaged.
Control Meniscus
Following tissue retrieval, the bovine meniscus implants 
were grossly examined and then bisected through the cen-
tral region of the created tear. These specimens were pri-
marily characterized as containing a conspicuous gap in the 
central region of the defect with no healing observed. The 
gap was easily distracted by minimal force with surgical 
forceps. In 4 meniscal implants some minimal reduction in 
gapping could be found in the peripheral margins of the 
defect only, but never in the central region. Histological 
evaluation by a blinded observer confirmed no cells or inte-
grative repair taking place in any of the control specimens 
(Fig. 1A-C). There was also a lack of host cell migration 
from the meniscus outward in an attempt to heal the defect. 
There was also no infiltration of host cells present from the 
nude rat host. None of the scaffolds or other delivery sys-
tems investigated resulted in any repair over just suture 
alone. Collagen scaffold material was observed in the gap in 
those specimens treated with scaffold alone, but lacking any 
cellular infiltration from the host meniscal cells.
Experimentally Treated Meniscus
Macroscopic examination of harvested menisci that 
received cell implants regardless of scaffold type all dem-
onstrated closure of the lesion with varying degrees of new 
filling. The thickness of the tissue filling the lesion gap was 
dependent on the type of scaffold implanted. The thickest 
tissue fill was observed in menisci that had received colla-
gen implants. The thinnest tissue fill occurred in menisci 
treated with cells alone (Fig. 2). Gross mechanical assess-
ment of the strength of the repair site demonstrated 
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adhesion that was not separated under moderate distraction 
by forceps. The strength of the bond also continued to 
improve with time in vivo. All menisci were prepared for 
histological examination and scored for their ability to 
bridge the gap defect with new tissue and synthesize colla-
gen into the extracellular space. There was general trend of 
better healing with time; thus, repair was significantly bet-
ter at 9 weeks compared with repair at 3 and 6 weeks.
Cell Labeling
Localization of cells by fluorescence microscopy was observed 
in all experimental groups that received cell transplants 
(Fig. 3). The number of cells did not decline with time as the 
9-week group demonstrated highly positively labeled cells still 
within the defect site. The cells in all groups remained local-
ized within their respective defect or carrier material and did 
not migrate into the host meniscus tissue to any large degree.
Effect of Scaffold
Meniscal repair in the cells alone group resulted in superior 
repair independent of tissue of origin when compared with 
the addition of scaffolds. The group with the next highest 
rate of repair was collagen gel, followed by the use of col-
lagen scaffold. Hyaluronic acid was the least effective of 
the scaffolds tested.
Effect of Cell Passage Number
There was no significant trend observed with respect to pas-
sage number regardless of cell type tested in their ability to 
bridge the experimental gap defect created. However, there 
was a subjective improvement in repair observed with cells 
that were in the early passage (p2 and p4) compared with 
later passage cells (p8). These observations were performed 
with the cells only group exclusive of the addition of a 
scaffold.
Effect of Cell Type
In comparing the cells with respect to tissue of origin, cells 
derived from menisci were able to repair defects faster and 
with more collagen than adipose or synovium derived cells. 
Adipose cells were the least effective in comparison. 
Synovial derived cells demonstrated a mixed capacity for 
cell-based repair.
Histological Grading
For cells alone, the mean histological scores for adipose, 
synovial, and meniscal groups were 1.55, 1.64, and 1.94, 
respectively (Fig. 4). A significant difference was found 
between the group means as determined by one-way 
ANOVA (P = 0.003). A post hoc Tukey HSD test showed 
Figure 1. Photomicrograph of control meniscus demonstrating conspicuous persistence of defect, unhealed at 3, 6, and 9 weeks post 
implantation (A, 3 weeks; B, 6 weeks; C, 9 weeks). Mallory trichrome, 100× original magnification.
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that there was a significant difference between the meniscus 
and adipose derived cell groups (P = 0.016) and the menis-
cus and synovium derived cell groups (P = 0.017). There 
was no significant difference between the adipose and 
synovium derived cell groups (P = 0.817). For the different 
time points, the mean histological scores for the 3-week, 
6-week, and 9-week groups were 1.33, 1.27, and 2.82, 
respectively (Fig. 5). A significant difference was found 
between the group means as determined by one-way 
ANOVA (P < 0.001). A post hoc Tukey HSD test showed 
that there was a significant difference between the 9-week 
and 3-week groups (P < 0.001) and the 9-week and 6-week 
groups (P < 0.001). There was no significant difference 
between the 6-week and 3-week groups (P = 0.871).
Figure 2. Photomicrograph of experimentally repaired meniscus with meniscal fibrochondrocytes. Note the integrative repair 
present by 9 weeks (A, 3 weeks; B, 6 weeks; C, 9 weeks). Mallory trichrome, 100× original magnification.
Figure 4. Histological scoring comparing the different cell 
types: adipose = 1.55, synovial = 1.64, and meniscal = 1.94.
Figure 3. Photomicrograph of implanted labeled synovial 
cells in defect under fluorescent optics at 200× magnification 
demonstrating original source of cells are from the transplanted 
population and their survival in vivo for 9 weeks.
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Discussion
King provided evidence that menisci will have a varied 
response to injury.2 From this early knowledge, intense 
debate and research have advanced efforts to repair and 
regenerate the meniscus. The meniscus is considered a vital 
tissue that imparts load-bearing properties, supplies nutri-
ents, and provides crucial joint stability to preserve joint 
biomechanics.1,2,11 Any loss or disruption of the meniscus 
may lead to irreversible degeneration of the articular carti-
lage. Injuries to the meniscus often do not heal well and 
currently available treatments are less than ideal. There is 
therefore a need for novel methods to repair the meniscus 
and prevent the onset of degenerative changes.
This study evaluated several cell-based strategies for 
repairing meniscal lesions. We sought to systematically 
determine the best cell type to use for clinical application, 
the effect of passage number on reparative capacity, and 
various delivery materials to augment meniscus repair. Our 
results demonstrate that delivery of cells alone outper-
formed the additional use of biomaterials. This was surpris-
ing because we hypothesized that the adjunct use of a 
scaffold would better retain the transplanted cells within the 
defect and serve as a network to more quickly immobilize 
recently synthesized collagen. The opposite finding was 
observed; scaffold materials impaired, depending on the 
type of material, the ability to biologically “weld” the defect 
sides.
The nude rat offers the potential to use xenografts to 
study integrative repair. This model also allows a large 
meniscus specimen to be studied and is more cost effective 
than studies with large animal models. However, the lack of 
mechanical load normally associated with weightbearing 
knee motion is a significant limitation of the nude rat 
model.20 Thus, the athymic rat model is useful as an initial 
screening system, but studies of new interventions eventu-
ally need to be conducted in a large animal model so that 
effects of weightbearing can be fully evaluated.
Our results are consistent with other similar studies by 
Perretti et al. and collaborators,21,22 who also studied cell-
based repair of meniscus using various approaches. Based 
on their successful findings with both autologous as well as 
allogeneic sources of cells, it is possible to envision a strat-
egy that would be able to bank both meniscus and synovial 
cells for arthroscopic meniscal repair.
Although the biomechanics of repaired menisci were not 
evaluated in this study, our microscopic results suggest that 
a similar level of material properties obtained in earlier 
studies by our group was achieved.23 To our knowledge, this 
is the first study to evaluate and compare different combina-
tions of cell types, tissue culture passage number, and bio-
material carriers for their effect on meniscus repair.
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